About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://www.weizmann-usa.org/news-media/feature-stories/maya-schuldiner-connecting-organelles/
Feb 15, 2022... Prof. Maya Schuldiner of Weizmann’s Department of Molecular Genetics studies how cells function, which in turn can help understand disease – particularly, rare diseases.In the end, it’s all about making a connection. In their recent study, Prof. Maya Schuldiner and her team from the Weizmann Institute of Science’s Molecular Genetics Department uncover for the first time how the cell’s Most Valuable Players – the nucleus and mitochondria – communicate through the formation of dedicated contact sites. Being able to tune in on these correspondences will allow scientists to better understand conditions where they are disrupted from cancer to neurodegenerative diseases. These findings join a series of recent discoveries in the budding field of contact site biology, some of which were made in Schuldiner’s lab.
Nov 21, 2022... Weizmann Scientist, Prof. Yonina Eldar of the department of Computer Science and Applied Mathematics, explains how Artificial Intelligence can be used to improve signal processing. Signal processing is a crucial component that enables many of the devices we use today including hearing aids and medical imaging equipment, like MRI, CT and X-ray, which can all greatly benefit from better imaging and resolution. Prof. Eldar’s specializes in developing algorithms for signal processing, and for the representation and transmission of information using advanced mathematical techniques. Her lab develops AI tools and to acquire and extract information and combine them with other modes like physics or medicine to pave the way to new technologies that can see, hear, and communicate beyond existing limits. Prof. Eldar’s innovations have helped to make ultrasound devices smaller, cheaper, and uploadable to the cloud; optimize MRI scans for medical imaging, improve data storage and communications, create super-resolution microscopy, and support computational biology.
https://www.weizmann-usa.org/news-media/in-the-news/2022-breakthroughs-of-the-year/
Dec 08, 2022...
Today, The Atlantic reveals its inaugural 10 Breakthroughs of the Year. The accomplishments span every station of life, from birth to death, and every component, from our cells to the stars. They include a drug that revives the organs of dead animals; an embryo created without sperm or egg; a telescope to see the universe’s first moments; and an AI that conjures award-winning art.
One theme of this year’s list is the principle of “twin ideas”—the tendency for major breakthroughs to have more than one author. The telegraph was invented by Charles Wheatstone and Samuel Morse in the same year, 1837, and patents for the telephone were filed by Elisha Gray and Alexander Graham Bell on the same day in 1876. Accordingly, many of this year’s breakthroughs are group efforts rather than individual awards. We didn’t just get one mind-blowing generative AI app this year; we got several in the span of a few months. We didn’t just get one “unheard-of” cancer breakthrough; we got several in one year. In this golden age of new vaccine technology, many different companies are building off the success of the COVID shots to deliver new antiviral weaponry for humankind.
https://www.weizmann-usa.org/news-media/in-the-news/scientists-debut-lab-models-of-human-embryos/
Jun 24, 2023... Scientists Debut Lab Models of Human Embryos
Aug 07, 2023...
REHOVOT, ISRAEL — August 8, 2023—Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that allow them to evade the medications’ therapeutic effect.
In research published today in the journal Cell Reports Medicine, investigators from the Weizmann Institute of Science report findings that may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists identified a biomarker that may help physicians treat select lung cancer patients with a single antibody-based drug that is likely to bring about full remission, without cancer relapse.
Aug 08, 2023...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, operate in stealth and cannot be targeted by the body’s regular immune system.
Edity Therapeutics, an Israeli startup founded in 2019, reprograms a patient’s own immune cells, giving them the ability to hunt down and destroy these cancer cells. It’s like transforming regular beat cops into lethal supersleuths.
Aug 08, 2023... Israeli study finds biological treatment effective for lung cancer